Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06945549

Evaluation of Intestinal Lesions and Disease Activity in Inflammatory Bowel Disease Based on 18F-FAPI PET Imaging

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to evaluate the role and effect of 18F-FAPI PET imaging in the identification of intestinal lesions and the assessment of disease activity in inflammatory bowel disease. The main question it aims to answer is: Can 18F-FAPI PET imaging effectively identify intestinal lesions in inflammatory bowel disease and accurately assess disease activity? Colonoscopy, enhanced abdominal CT, and 18F-FAPI intestinal imaging were completed within 1 week, and major adverse outcomes (MAO) were followed up 12 months after enrollment. Last updated on March 25, 2025

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST18F-FAPI PET ImagingThe ROI of the target lesions was delineated based on 18F-FAPI PET Imaging, and the lesions were divided on the cross section to obtain the lesions SUVmax, SUVmean, SUVpeak, FAPI metabolic volume (FAV), MTV, TBR, and TLG.

Timeline

Start date
2025-04-25
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2025-04-25
Last updated
2025-06-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06945549. Inclusion in this directory is not an endorsement.